Brief: Axovant Gene Therapies Posts Q3 Loss Per Share Of $0.62

Sio Gene Therapies

10/02/2020 11:34

Feb 10 (Reuters) - Axovant Gene Therapies Ltd  AXGT.O :
    * AXOVANT ANNOUNCES FINANCIAL RESULTS FOR THIRD FISCAL
QUARTER AND
NINE MONTHS ENDED DECEMBER 31, 2019
    * Q3 LOSS PER SHARE $0.62
    * Q3 EARNINGS PER SHARE ESTIMATE $-0.67 -- REFINITIV IBES
DATA

Source text for Eikon:  ID:nGNX9fHrqZ 
Further company coverage:  AXGT.O 

 ((Reuters.Briefs@thomsonreuters.com;))